Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy

Convalescent plasma has been extensively tested during the COVID-19 pandemic as a transfusion product. Similarly, monoclonal antibodies have been largely administered either intravenously or intramuscularly. Nevertheless, when used against a respiratory pathogen, respiratory delivery is preferable t...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Maggi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561570/
https://www.ncbi.nlm.nih.gov/pubmed/37799070
http://dx.doi.org/10.1080/21645515.2023.2260040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561570/
https://www.ncbi.nlm.nih.gov/pubmed/37799070
http://dx.doi.org/10.1080/21645515.2023.2260040

Ejemplares similares